mAbXcite: a novel immunotherapy platform that initiates a robust anti-cancer immune response by recruiting and activating neutrophils
Year: 2014
Type: article
Abstract: Meeting abstracts The recent successes in the immunotherapy field demonstrate that a successful immune response to cancer can lead to meaningful anti-tumor responses. Antibodies blocking immune checkpoint molecules (e.g. CTLA4, and PD-1) lead to effective T cell responses especially in tumors that
Authors: Ifat Rubin-Bejerano, Isabelle Sansal-Castellano, Mark Carlson, Gabriel Reznik, James Siedlecki, John Kane, Zuzana Dostalova, Hua Miao
Institution: ImmuneXcite (United States)
Language: English
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Open Access status: gold
Estimated APC paid: $2,490
OpenAlex ID: W2055758548